204 results
Page 5 of 11
6-K
EX-99.1
f5uipj9g86q8
8 Apr 21
Bellus HEALTH 2020 ANNUAL REPORT
10:16am
6-K
EX-99.1
po3 vq9s46105o
24 Mar 21
BELLUS Health Appoints William Mezzanotte, MD, MPH to its Board of Directors
7:00am
40-F
EX-99.1
545l6q 1s
25 Feb 21
Annual report (Canada)
4:58pm
40-F
EX-99.2
vz9m43
25 Feb 21
Annual report (Canada)
4:58pm
40-F
EX-99.3
blwfp48yq7 y5j6d6
25 Feb 21
Annual report (Canada)
4:58pm
6-K
EX-99.1
4ocsfsuynv1
25 Feb 21
BELLUS Health Reports Year 2020 Financial Results and Business Highlights
4:02pm
6-K
EX-99.1
4yyf3s41z1csq
22 Feb 21
BELLUS Health to Participate in Two Upcoming Healthcare Investor Conferences
7:00am
6-K
EX-99.1
am6q j7f4d3g4zap5z4
14 Jan 21
Bellus Health Inc. 6-K
7:00am
6-K
EX-99.2
ng0t8pn
23 Dec 20
Open Market Sale Agreementsm
5:06pm
SUPPL
au7qtn7wd4cb04ylbba7
23 Dec 20
Supplemental materials (foreign)
5:01pm
F-10/A
9vrf112ak93mg e7
23 Dec 20
Registration of securities (Canada) (amended)
4:06pm
F-10
EX-4.8
5821o q2303chw8c
14 Dec 20
Registration of securities (Canada)
4:18pm
F-10
e3q6yxz d54owzli
14 Dec 20
Registration of securities (Canada)
4:18pm
6-K
EX-99.1
96lmh67fwb4jrbea7tdv
14 Dec 20
Bellus Health Inc. Form 6-K
7:01am
6-K
2bajt013
14 Dec 20
Bellus Health Inc. Form 6-K
7:01am
6-K
EX-99.1
eeuubyt6
8 Dec 20
BELLUS Health Announces First Patient Dosed in its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:00am
6-K
el9qkc2ir3y5fgt
8 Dec 20
BELLUS Health Announces First Patient Dosed in its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:00am
6-K
EX-99.1
c9xe7
7 Dec 20
Bellus Health Inc. 6-K
7:01am
6-K
EX-99.1
4uernrhp
24 Nov 20
BELLUS Health to Participate in the Evercore ISI 3rd Annual Virtual HealthCONx Conference
7:00am
6-K
EX-99.1
stk4dwuaw3lmvqtf9e
12 Nov 20
Condensed Consolidated Interim Financial Statements of
4:09pm